SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-005156
Filing Date
2024-02-23
Accepted
2024-02-23 20:33:43
Documents
1
Period of Report
2024-02-21

Document Format Files

Seq Description Document Type Size
1 form4-02242024_010232.html 4  
1 form4-02242024_010232.xml 4 6460
  Complete submission text file 0001415889-24-005156.txt   7861
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Issuer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FIBROGEN, INC. 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address
Wettig Thane (Reporting) CIK: 0001815638 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36740 | Film No.: 24673318